How Bacterial Vaginosis Happens: Causes & Triggers

Bacterial vaginosis starts when the community of bacteria living in the vagina shifts away from its normal, protective makeup. In a healthy state, the vagina is dominated by lactic acid-producing bacteria that keep the environment acidic and inhospitable to harmful organisms. BV develops when those protective bacteria lose their foothold and are replaced by a diverse mix of anaerobic species that thrive at higher pH. The process is not a simple infection caught from a single germ but a cascading ecological collapse, and the triggers range from sexual activity and douching to hormonal changes and even a partner’s microbial profile.

What the Healthy Vaginal Environment Looks Like

Understanding how BV happens requires knowing what it disrupts. The vaginal lining is rich in glycogen, a starchy sugar that feeds Lactobacillus species. These bacteria ferment glycogen into lactic acid, driving the vaginal pH down to roughly 3.5–4.5. That acidic environment is the vagina’s main line of defense: most harmful bacteria struggle to grow at such a low pH.¹ A high concentration of lactic acid is one of the clearest markers separating a balanced vaginal state from a disrupted one. When lactobacilli decline, lactic acid drops, pH rises, and anaerobic bacteria seize the opportunity.²

This lactobacillus-dominated setup appears to be uniquely human. In other mammals, lactobacilli rarely make up more than about 1% of the vaginal microbial community, while in reproductive-age humans the figure is typically above 70%.³ Other primates show far more diverse vaginal communities without the heavy Lactobacillus presence.⁴ Why humans evolved this arrangement is still debated, but the practical consequence is that our reproductive tract depends heavily on a single bacterial genus for protection, which makes it vulnerable when that genus is knocked back.

The Microbial Takeover

BV is not caused by one invading pathogen. It is a polymicrobial condition in which dozens of anaerobic species proliferate once lactobacilli lose ground. The bacterium most consistently linked to early-stage BV is Gardnerella vaginalis, which has the ability to adhere to vaginal epithelial cells and establish a structured biofilm, a thin, sticky layer of bacteria clinging to the vaginal wall.⁵ Once that biofilm is in place, other BV-associated species like Atopobium vaginae and Prevotella bivia join the community. They do not necessarily add bulk to the biofilm, but they alter how it functions, influencing gene activity in G. vaginalis and helping the whole structure persist.⁵

This biofilm is a major reason BV is so stubborn. Not every strain of G. vaginalis is equally dangerous. Research on isolates from women in northeast China found that roughly half of the G. vaginalis samples tested could form biofilms, while the rest could not. Among biofilm-forming samples, most produced weak biofilms. Yet even weak biofilms confer a survival advantage: the bacteria within them are sheltered from antibiotics and the immune system in ways that free-floating bacteria are not.⁶

G. vaginalis also attacks the body’s physical defenses. It produces an enzyme called sialidase that chews through the mucus lining of the vagina, breaking down protective sugar molecules. This degradation strips away a barrier that normally helps keep harmful microbes at bay, and it has been confirmed in clinical samples from women with BV.⁷ The sialidase gene was found in 100% of tested G. vaginalis isolates in one study, suggesting this mucus-destroying capability is nearly universal in the species.⁶

Sexual Activity and Partner Transmission

BV has long occupied an awkward category: it behaves in some ways like a sexually transmitted infection but does not fit the classic STI model. The evidence increasingly points toward sexual exchange of bacteria as a major trigger, even if BV can also occur in women who are not sexually active.

A conceptual model published in the Journal of Infectious Diseases proposed that BV is initiated by the sexual transmission of virulent strains of G. vaginalis, which then outcompete lactobacilli and create a biofilm that allows other anaerobes to flourish.⁸ Several studies support this picture. In monogamous heterosexual couples where the woman has BV, researchers have found that the bacterial communities on the man’s penile skin and in his urethra are significantly more similar to the woman’s vaginal bacteria than in couples without BV, pointing to ongoing bacterial exchange.⁹

Research from Uganda found that the composition of bacteria on the penis was significantly associated with BV in female partners, and that men with extramarital sexual relationships carried more BV-associated anaerobes, mirroring patterns seen in women with multiple partners.¹⁰ A separate study went further, showing that the bacterial profile on a man’s penis could predict with high accuracy whether his female partner would develop new BV. The most predictive bacteria were the same species found in the vagina during BV, including Gardnerella vaginalis and Sneathia sanguinegens.¹¹

Semen itself may also play a role independent of the bacteria it carries. Semen is alkaline, with a pH well above the 4.5 threshold where lactobacilli thrive. Exposure to semen temporarily raises vaginal pH, creating a window where BV-associated species like Gardnerella and Prevotella can gain a foothold.¹² These microbial changes from semen exposure are likely short-lived on their own, but in a woman whose vaginal ecology is already borderline, they could tip the balance.

Douching and Other Behavioral Triggers

Vaginal douching is one of the most well-documented behavioral triggers for BV. A large longitudinal study found that women who douched regularly had about a 21% higher risk of disrupted vaginal flora compared with women who did not douche.¹³ Douching was associated with higher levels of G. vaginalis and Mycoplasma hominis, as well as a reduction in hydrogen peroxide-producing lactobacilli, the very species that anchor the healthy vaginal ecosystem.¹⁴

Lab research has shed light on why different douching products cause trouble in different ways. When researchers exposed vaginal Lactobacillus species and E. coli to commercial douching solutions, all products killed E. coli effectively, but only the baking soda-based product significantly inhibited Lactobacillus growth. The iodine and vinegar products were less harmful to lactobacilli at standard concentrations but still affected the vaginal epithelial lining, altering the immune signals produced by vaginal cells.¹⁵ The takeaway is that no douching product is benign: even when they spare lactobacilli directly, they can disrupt the immune environment of the vagina, opening a path for opportunistic bacteria.

Hormones, Estrogen, and Glycogen

Estrogen is the upstream hormone that keeps the whole protective system running. It drives the vaginal epithelium to produce glycogen, the sugar that feeds lactobacilli.¹⁶ When estrogen levels drop, glycogen production falls, lactobacilli lose their food source, and pH rises. This is why BV risk tracks with hormonal shifts across a woman’s life: it is most common during the reproductive years (when the vaginal microbiome is most dynamic), and the specific timing within a menstrual cycle matters too, since estrogen fluctuates throughout each month.

Menopause, breastfeeding, and certain hormonal medications all lower estrogen and can shift the vaginal microbiome toward the kind of diversity seen in BV. Conversely, hormonal contraceptives that contain estrogen tend to stabilize the lactobacillus-dominant community. The copper intrauterine device, which contains no hormones, has been linked to higher BV rates. A prospective study found that copper IUD users experienced about 28% higher BV risk compared to women using no contraception or other nonhormonal methods.¹⁷ The mechanism behind this is not fully settled. It could involve localized inflammation from the device, changes in menstrual bleeding patterns, or both. But the pattern underscores how even non-chemical interventions in the reproductive tract can influence microbial balance.

Genetic Susceptibility

Not everyone exposed to the same triggers develops BV, which has led researchers to look at host genetics. The immune system’s ability to detect and respond to vaginal bacteria depends partly on toll-like receptors and related pattern recognition molecules on mucosal cells. Variations in the genes for these receptors appear to influence BV risk.

A study of women living with and at risk for HIV found that genetic variations in mucosal defense genes, including those coding for syndecans, cytokines, and toll-like receptors, were associated with BV across multiple ancestral groups.¹⁸ Research focused specifically on toll-like receptor genes in African women found that certain variants in TLR7 were linked to either increased or decreased BV risk, and that the associations differed depending on HIV status.¹⁹ A separate study in pregnant women found that polymorphisms in several immune recognition genes, including CD14 and TLR1, were associated with vaginal carriage of A. vaginae, one of the key BV-associated organisms.²⁰

These findings are still being mapped out, and no single gene variant has emerged as a dominant predictor. But the overall picture suggests that some women are immunologically primed to tolerate or even welcome BV-associated bacteria, while others mount a mucosal defense that keeps those organisms in check. This partly explains the frustrating pattern many women experience: same behavior, same partner, same hygiene habits, yet BV keeps coming back for some and not others.

Why BV Recurs So Often

Recurrence is one of the most maddening features of BV. Standard antibiotic treatment with metronidazole or clindamycin clears symptoms in most cases, but the condition returns within months for a large share of women. The biofilm is the main culprit. Antibiotics kill free-floating bacteria effectively but cannot fully eradicate bacteria embedded in a biofilm on the vaginal wall.²¹ Once a course of antibiotics ends, surviving biofilm bacteria repopulate the vagina rapidly.

Sexual reinfection also contributes. If a male partner continues to harbor BV-associated organisms on the penile skin, condomless sex can reintroduce those bacteria after treatment. Research from Rakai, Uganda explicitly suggested that reducing bacterial exchange through barrier methods and managing the carriage of BV-associated bacteria in men could decrease BV persistence and recurrence in women.¹⁰ Clinical trials testing concurrent partner treatment are underway, but until partner treatment becomes standard practice, this reinfection loop remains a major driver of recurrence.

The metronidazole resistance profile adds another wrinkle. In one set of G. vaginalis isolates, nearly 88% showed resistance to metronidazole, while about two-thirds were sensitive to clindamycin.⁶ That does not mean metronidazole never works; the clinical picture involves many bacterial species, and the drug targets anaerobes broadly. But it does help explain why some women respond poorly to first-line therapy.

What BV Does Beyond Symptoms

The fishy odor and thin discharge that define BV are uncomfortable, but the consequences extend beyond symptoms. BV is the leading gynecological condition in women of reproductive age globally, and it raises the risk of acquiring sexually transmitted infections, including HIV.²² The mechanisms behind this increased susceptibility include the disruption of the mucosal barrier and the induction of inflammatory signals in the genital tract.²³ When the mucus lining is degraded and the immune environment is altered, sexually transmitted pathogens face fewer obstacles to establishing infection.

BV also carries reproductive consequences. It has been linked to increased rates of preterm birth, pelvic inflammatory disease, and infertility.²² For women trying to conceive, whether naturally or through assisted reproduction, an unresolved BV episode can interfere with implantation and early pregnancy. These downstream effects are what elevate BV from an annoyance to a genuine public health concern.

The Gut-Vaginal Connection

An emerging area of research links the vaginal microbiome to the gut. The vaginal microbial community appears to have developed partly through continuous translocation of species from the intestinal tract, as well as through mother-to-child transfer during birth.²⁴ Once in the vagina, these organisms retain their basic biochemical traits but trigger different immune responses than they do in the gut. This matters because it suggests that disruptions in gut health, whether from antibiotics, diet, or illness, could ripple into vaginal microbial composition. The research is still early, and no one has established a reliable causal chain from, say, oral antibiotics to BV via gut disruption. But the anatomical proximity and shared bacterial lineages make the gut a plausible upstream reservoir worth watching.

Some researchers have speculated that this gut-vaginal axis could eventually become a target for prevention. If the right Lactobacillus strains could be encouraged to migrate from a well-stocked gut community to the vagina, it might offer a way to shore up vaginal defenses without relying solely on vaginal probiotics, which so far have shown mixed results in clinical trials. For now, this remains a hypothesis rather than a clinical recommendation, but it reflects how the understanding of BV is expanding well beyond the vagina itself.

1
PubMed Central. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli
2
PubMed. The role of lactic acid production by probiotic Lactobacillus species in vaginal health
3
PubMed Central. Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique?
4
American Journal of Physical Anthropology. The primate vaginal microbiome: comparative context and implications for human health and disease
5
PubMed Central. Atopobium vaginae and Prevotella bivia Are Able to Incorporate and Influence Gene Expression in a Pre-Formed Gardnerella vaginalis Biofilm
6
PubMed Central. Biofilm and pathogenic factor analysis of Gardnerella vaginalis associated with bacterial vaginosis in Northeast China
7
PubMed Central. Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis
8
The Journal of Infectious Diseases. Role of Gardnerella vaginalis in the Pathogenesis of Bacterial Vaginosis: A Conceptual Model
9
PubMed Central. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis
10
PubMed Central. Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
11
PubMed Central. The Microbiome Composition of a Man’s Penis Predicts Incident Bacterial Vaginosis in His Female Sex Partner With High Accuracy
12
PubMed Central. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women
13
PubMed Central. A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis—A Marginal Structural Modeling Analysis
14
PubMed. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina
15
Scientific Reports. Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses
16
PubMed Central. Unraveling the Dynamics of the Human Vaginal Microbiome
17
PubMed Central. Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study
18
PubMed Central. Genetic predictors for bacterial vaginosis in women living with and at risk for HIV infection
19
PubMed Central. Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women
20
PubMed. Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae
21
PubMed Central. Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions
22
PubMed. The vaginal microbiome in bacterial vaginosis: Pathogenesis, reproductive impacts, and emerging therapies
23
PubMed Central. The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract
24
PubMed Central. Female Gut and Genital Tract Microbiota-Induced Crosstalk and Differential Effects of Short-Chain Fatty Acids on Immune Sequelae